Cargando…

CAR T-cell Infusion Following Checkpoint Inhibition Can Induce Remission in Chemorefractory Post-transplant Lymphoproliferative Disorder of the CNS

Detalles Bibliográficos
Autores principales:	Rösler, Wiebke, Bink, Andrea, Bissig, Marina, Imbach, Lukas, Marques Maggio, Ewerton, Manz, Markus G., Müller, Thomas, Roth, Patrick, Rushing, Elisabeth, Widmer, Corinne, Zenz, Thorsten, von Moos, Seraina, Müller, Antonia M. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208876/ https://www.ncbi.nlm.nih.gov/pubmed/35747591 http://dx.doi.org/10.1097/HS9.0000000000000733

Ejemplares similares

Haploidentical γδ T Cells Induce Complete Remission in Chemorefractory B-cell Non-Hodgkin Lymphoma
por: Bold, Anna, et al.
Publicado: (2023)

Cancer among kidney transplant recipients >20 years after transplantation: post-transplant lymphoproliferative disorder remains the most common cancer type in the ultra long-term
por: Fuhrmann, Julia D, et al.
Publicado: (2022)

BRAF inhibitor treatment of classical hairy cell leukemia allows successful vaccination against SARS-CoV-2
por: Konrat, Judith, et al.
Publicado: (2022)

Eosinophilic granulomatosis with polyangiitis (EGPA) on remission with a new neuropathy: a rare case of mycophenolate induced primary CNS lymphoproliferative disease
por: Shrestha, Pragya, et al.
Publicado: (2020)

Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usage
por: Crane, Genevieve M., et al.
Publicado: (2015)

A Rare Presentation of Isolated CNS Posttransplantation Lymphoproliferative Disorder
por: Morris, Jaime, et al.
Publicado: (2017)

GOALs in relapsed DLBCL
por: Rösler, Wiebke, et al.
Publicado: (2022)

Role of delayed salvage bevacizumab at symptomatic progression of chemorefractory glioblastoma
por: Cuncannon, Moire, et al.
Publicado: (2019)

Comparing the Secretomes of Chemorefractory and Chemoresistant Ovarian Cancer Cell Populations
por: Lee, Amy H., et al.
Publicado: (2022)

Secondary CNS myeloma with remission after systemic CNS-penetrating agents
por: Fernandez, Luis G, et al.
Publicado: (2022)

S257: CAR T CELLS AND THEIR IMMUNE ENVIRONMENT SHAPE DISTINCT IMMUNE PROFILES IN RESPONSE AND TOXICITY IN B CELL LYMPHOMA PATIENTS
por: Kreutmair, Stefanie, et al.
Publicado: (2023)

Case Report: Subtotal Lymphoid and Total Marrow Irradiation as Bridge Therapy to CD19-Directed CAR T Cells in a Chemorefractory DLBCL With Leukemic Involvement
por: Saldi, Simonetta, et al.
Publicado: (2022)

Anakoinosis: Communicative Reprogramming of Tumor Systems - for Rescuing from Chemorefractory Neoplasia
por: Hart, Christina, et al.
Publicado: (2015)

Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers
por: Hancock, Bradley A., et al.
Publicado: (2019)

Readministration of Cancer Drugs in a Patient with Chemorefractory Metastatic Colorectal Cancer
por: Kawagoe, Tetsuro, et al.
Publicado: (2020)

Chemorefractory Gastric Cancer: The Evolving Terrain of Third-Line Therapy and Beyond
por: Alsina, Maria, et al.
Publicado: (2022)

CAR T-cell therapy for secondary CNS DLBCL
por: Ahmed, Gulrayz, et al.
Publicado: (2021)

The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice
por: Cerrano, Marco, et al.
Publicado: (2020)

Efficacy and safety of the third-generation chloroethylnitrosourea fotemustine for the treatment of chemorefractory T-cell lymphomas
por: Corazzelli, Gaetano, et al.
Publicado: (2011)

Bevacizumab plus chemotherapy as salvage treatment in chemorefractory patients with metastatic colorectal cancer
por: Geva, Ravit, et al.
Publicado: (2013)

Gemcitabine plus capecitabine (Gem–Cape) biweekly in chemorefractory metastatic colorectal cancer
por: Jiménez-Fonseca, P., et al.
Publicado: (2014)

The role of large volume re-irradiation with Bevacizumab in chemorefractory high grade glioma
por: Chan, Joseph, et al.
Publicado: (2020)

Pericardial Effusion during Proton Therapy in a Patient with Chemorefractory Hodgkin Lymphoma
por: Way, Ashley, et al.
Publicado: (2021)

CAR T-Cells for CNS Lymphoma: Driving into New Terrain?
por: Karschnia, Philipp, et al.
Publicado: (2021)

Post-Transplant Lymphoproliferative Disorder: A Rare Case of CNS Involvement following Renal Transplant
por: Feindt, Austin, et al.
Publicado: (2022)

Molecular profiling identifies at least 3 distinct types of posttransplant lymphoproliferative disorder involving the CNS
por: Guney, Ekin, et al.
Publicado: (2023)

Erratum to: Gemcitabine plus capecitabine (Gem–Cape) biweekly in chemorefractory metastatic colorectal cancer
por: Jiménez-Fonseca, P., et al.
Publicado: (2014)

Genomic mutations and histopathologic biomarkers in Y(90) radioembolization for chemorefractory colorectal liver metastases
por: Dendy, Meaghan S., et al.
Publicado: (2018)

RETRO-TAS, a Retrospective Observational Study of Trifluridine/Tipiracil in Chemorefractory Metastatic Colorectal Cancer
por: Koumarianou, Anna, et al.
Publicado: (2023)

Tisagenlecleucel: The First CAR on the Highway to Remission for Acute Lymphoblastic Leukemia
por: Freyer, Craig W.
Publicado: (2018)

CAR T cells remain during long-term cancer remission
por: Barnes, Katharine
Publicado: (2022)

A unique case of a fulminant clonal CD8-positive T-cell lymphoproliferative disorder with CNS involvement
por: Mesbah-Oskui, Lia, et al.
Publicado: (2023)

Induction and progression of human lymphoproliferative lesions by Epstein-Barr virus.
por: Chappuis, B B, et al.
Publicado: (1990)

CD22-CAR T Cells Induce Remissions in CD19-CAR Naïve and Resistant B-ALL
por: Fry, Terry J., et al.
Publicado: (2017)

Therapeutic potential of antiviral drugs targeting chemorefractory colorectal adenocarcinoma cells overexpressing endogenous retroviral elements
por: Díaz-Carballo, David, et al.
Publicado: (2015)

Chemorefractory liver metastasis from cervical cancer successfully treated with a combination of yttrium-90 and immunotherapy
por: Nance, Michael E., et al.
Publicado: (2020)

Long-Time Progression-Free Survival with Trabectedin in Chemorefractory Metastatic Leiomyosarcoma of the Retroperitoneum: A Case Report
por: Reichinger, Andreas
Publicado: (2023)

Primary CNS post-transplant lymphoproliferative disorder following haploidentical HSCT using post-transplant high-dose cyclophosphamide
por: Toyosaki, Masako, et al.
Publicado: (2018)

Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma
por: Raj, Deepak, et al.
Publicado: (2019)

BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphoma
por: Raghunandan, Sharmila, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5vdnan800tgc490uti3kt9af36